Short answer
Labcorp (LH) filed an 8-K current report with the SEC on April 30, 2026 reporting Item EX-99.1 (Exhibit EX-99.1). Q1 revenue $3.54B, up 5.8%, with organic growth 3.1% and adjusted EPS $4.25, up 10.6%.
Labcorp 8-K event analysis
AI summary of each reported item and its exhibits
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue $3.54B, up 5.8%, with organic growth 3.1% and adjusted EPS $4.25, up 10.6%
- Operating margin improved to 10.8% from 9.7%; adjusted margin reached 14.4% from 14.0%
- Diagnostics revenue rose 5.0% to $2.76B; Biopharma revenue increased 8.2% to $780.6M
- Full-year revenue guidance raised to $14.65B-$14.80B; adjusted EPS increased to $17.70-$18.35
- Capital deployment included $202.2M acquisitions, $98.0M buybacks, and $61.2M dividends; total debt reached $6.33B
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Labcorp 8-K filings
Get the next LH 8-K as it lands
Follow LH for push alerts, or ask the research agent what this filing means.